🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In Brief: Opus Gears Up For FDA Filing In Presbyopia — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8b2zp vist.ly/3n8b2zq

BlissBio Goes Solo On HER2-Targeting ADC After Eisai Exit — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8c6kx vist.ly/3n8c6ky

In Brief: Atai-Beckley Deal Marches On After Phase II Psychedelic Win — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8csyg vist.ly/3n8csyh

BerGenBio Plumps For Oncoinvent From Long List Of 50 Suitors — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8cwxt vist.ly/3n8cwxu

Bluebird Builds Out Leadership Team Under Private Equity Ownership — Click image below to read more! || #Scrip | Start your free trial today: citeline.com/en/app-insight… feeds.feedblitz.com/~/921077567/0/…

In Brief: BioVersys And Shionogi Align In Non-Tuberculous Mycobacteria R&D — Click image below to read more! || #Scrip | Start your free trial today: citeline.com/en/app-insight… feeds.feedblitz.com/~/921075194/0/…

Regeneron Wins Long-Sought FDA Nod For Lynozyfic In Myeloma — Click image below to read more! || #Scrip | Start your free trial today: citeline.com/en/app-insight… feeds.feedblitz.com/~/921081221/0/…

Beyond AI Hype: Tokyo-1’s Real Answer On How To Innovate Pharma R&D — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8eiwb vist.ly/3n8eiwc

In Brief: 4DMT Fast-Tracks Long-Acting Wet AMD Therapy Trials, Cuts 25% Of Workforce — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8enh4 vist.ly/3n8enh5

In Brief: Organon To Pull Plug On OG-6219 Program After Phase II Endometriosis Trial Failure — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8f9ct vist.ly/3n8f9cu

Novartis’s Cosentyx Suffers Rare Phase III Fail — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8fd4v vist.ly/3n8fd4w

Executives On The Move: New CEOs At Sun Pharma And TME Pharma — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8fh39 vist.ly/3n8fh3a

Dizal’s Zegfrovy Wins US NSCLC Approval, At Lower Dose Than In China — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8h9jf vist.ly/3n8h9jg

BioMarin’s Roctavian Continues to Shine In Hemophilia A Despite Commercial Woes — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8hdb4 vist.ly/3n8hdb5

Eolo Pharma Advances In Obesity With Thermogenesis Approach — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8hqua vist.ly/3n8hqub

2025’s Biggest Launches – Half-Year Progress Report — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8huva vist.ly/3n8huvb

Compass Pathways’ Antidepressant Advances In An Increasingly Tough Psychedelic Market — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8hyqq vist.ly/3n8hyqr

Will AstraZeneca Reach Summit And Be A PD-1xVEGF Player? — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8i4hs vist.ly/3n8i4ht

Second Quarter M&A Activity Looks Like More Of The Same, Mostly — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8iu4x vist.ly/3n8iu4y

How Teva Is Expanding Innovation To Fuel ‘Pivot To Growth’ — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/3n8ixzd vist.ly/3n8ixze